Uncertainty as to whether the use of antiretroviral therapy for persons recently infected with HIV has a favorable risk-to-benefit ratio

Clin Infect Dis. 2009 Apr 15;48(8):1162; author reply 1162-3. doi: 10.1086/597495.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Anti-HIV Agents / adverse effects*
  • Anti-HIV Agents / therapeutic use*
  • HIV Infections / drug therapy*
  • Humans
  • Randomized Controlled Trials as Topic
  • Risk Assessment

Substances

  • Anti-HIV Agents